Companies / Chile
USTR Places Chile On Priority Watch List
January 2007 | Trade AlertThe Office of the US Trade Representative (USTR) has elevated Chile from its "Watch List" to the "Priority Watch List" for alleged failure to comply with US standards for intellectual property rights protection, particularly in the areas of pharmaceuticals and software. While this development has minimal material impact for drugmakers operating in Chile, BMI believes that it is a further example of the influence of pharmaceutical companies on US government policy.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Americas Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Americas Pharma & Healthcare Insight please click on the trial link below.
